Announcing a new article publication for Zoonoses journal. The COVID-19 pandemic threatens public health systems worldwide, both in developed and developing countries.
Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures | Psychedelic Invest
TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused